These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24129363)

  • 21. Effect of a mediterranean-style diet on endothelial dysfunction and markers of vascular inflammation in the metabolic syndrome: a randomized trial.
    Esposito K; Marfella R; Ciotola M; Di Palo C; Giugliano F; Giugliano G; D'Armiento M; D'Andrea F; Giugliano D
    JAMA; 2004 Sep; 292(12):1440-6. PubMed ID: 15383514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A very low-carbohydrate, low-saturated fat diet for type 2 diabetes management: a randomized trial.
    Tay J; Luscombe-Marsh ND; Thompson CH; Noakes M; Buckley JD; Wittert GA; Yancy WS; Brinkworth GD
    Diabetes Care; 2014 Nov; 37(11):2909-18. PubMed ID: 25071075
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Close adherence to a Mediterranean diet improves endothelial function in subjects with abdominal obesity.
    Rallidis LS; Lekakis J; Kolomvotsou A; Zampelas A; Vamvakou G; Efstathiou S; Dimitriadis G; Raptis SA; Kremastinos DT
    Am J Clin Nutr; 2009 Aug; 90(2):263-8. PubMed ID: 19515732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized crossover study to assess the effect of an oat-rich diet on glycaemic control, plasma lipids and postprandial glycaemia, inflammation and oxidative stress in Type 2 diabetes.
    McGeoch SC; Johnstone AM; Lobley GE; Adamson J; Hickson K; Holtrop G; Fyfe C; Clark LF; Pearson DW; Abraham P; Megson IL; MacRury SM
    Diabet Med; 2013 Nov; 30(11):1314-23. PubMed ID: 23668675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of oat bran reduces HDL-C and does not potentialize effect of a low-calorie diet on remission of metabolic syndrome: A pragmatic, randomized, controlled, open-label nutritional trial.
    Leão LSCS; Aquino LA; Dias JF; Koifman RJ
    Nutrition; 2019 Sep; 65():126-130. PubMed ID: 31082790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of different dietary approaches on glycemic control and cardiovascular risk factors in patients with type 2 diabetes: a protocol for a systematic review and network meta-analysis.
    Schwingshackl L; Chaimani A; Hoffmann G; Schwedhelm C; Boeing H
    Syst Rev; 2017 Mar; 6(1):57. PubMed ID: 28320464
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort.
    Bo S; Durazzo M; Guidi S; Carello M; Sacerdote C; Silli B; Rosato R; Cassader M; Gentile L; Pagano G
    Am J Clin Nutr; 2006 Nov; 84(5):1062-9. PubMed ID: 17093158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome.
    Arca M
    Drugs; 2007; 67 Suppl 1():43-54. PubMed ID: 17910520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle weight-loss intervention outcomes in overweight and obese adults with type 2 diabetes: a systematic review and meta-analysis of randomized clinical trials.
    Franz MJ; Boucher JL; Rutten-Ramos S; VanWormer JJ
    J Acad Nutr Diet; 2015 Sep; 115(9):1447-63. PubMed ID: 25935570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multifunctional diet improves cardiometabolic-related biomarkers independently of weight changes: an 8-week randomized controlled intervention in healthy overweight and obese subjects.
    Tovar J; Johansson M; Björck I
    Eur J Nutr; 2016 Oct; 55(7):2295-306. PubMed ID: 26370118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nutritional management of cardiovascular risk factors. A randomized clinical trial.
    McCarron DA; Oparil S; Chait A; Haynes RB; Kris-Etherton P; Stern JS; Resnick LM; Clark S; Morris CD; Hatton DC; Metz JA; McMahon M; Holcomb S; Snyder GW; Pi-Sunyer FX
    Arch Intern Med; 1997 Jan; 157(2):169-77. PubMed ID: 9009974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 6-month follow-up study of the randomized controlled Ma-Pi macrobiotic dietary intervention (MADIAB trial) in type 2 diabetes.
    Soare A; Del Toro R; Khazrai YM; Di Mauro A; Fallucca S; Angeletti S; Skrami E; Gesuita R; Tuccinardi D; Manfrini S; Fallucca F; Pianesi M; Pozzilli P
    Nutr Diabetes; 2016 Aug; 6(8):e222. PubMed ID: 27525817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The association of metabolic syndrome components and diabetes mellitus: evidence from China National Stroke Screening and Prevention Project.
    Li W; Wang D; Wang X; Gong Y; Cao S; Yin X; Zhuang X; Shi W; Wang Z; Lu Z
    BMC Public Health; 2019 Feb; 19(1):192. PubMed ID: 30764803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
    Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and diabetes.
    Huo X; Spatz ES; Ding Q; Horak P; Zheng X; Masters C; Zhang H; Irwin ML; Yan X; Guan W; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM; Jiang L
    BMJ Open; 2017 Dec; 7(12):e018302. PubMed ID: 29273661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High Prevalence of Vitamin D Deficiency and Correlation of Serum Vitamin D with Cardiovascular Risk in Patients with Metabolic Syndrome.
    Alkhatatbeh MJ; Abdul-Razzak KK; Khasawneh LQ; Saadeh NA
    Metab Syndr Relat Disord; 2017 Jun; 15(5):213-219. PubMed ID: 28346853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study.
    Ogedengbe S; Ezeani IU; Aihanuwa E
    Endocr Regul; 2016 Jan; 50(1):32-40. PubMed ID: 27560635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.